The Cancer

Don't Miss

News

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Editor -
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
News

How Most cancers Stole My Peace of Thoughts and Taught Me Resilience

Editor -
Being robbed is simply part of life.Once I was in grammar college, little girls and boys would copy off my exams, stealing my solutions to...
News

FDA Clears PD-L1 Check to Information Keytruda Use in Ovarian Most cancers

Editor -
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Load more

Vital Information

Load more

Facts

Latest Articles

Colorectal

Bowel most cancers is on the rise. Right here’s how immunotherapy medicine may assist

Editor -
Vikram Reddy: ...
Lung

Roche to halt trial for lung most cancers therapy after 'disappointing' outcomes – XM

Editor -
Roche to halt trial for lung most cancers therapy after 'disappointing' outcomes  XM
Prostate

$1.6B might await Orion in up to date Merck prostate most cancers deal

Editor -
Merck & Co. Inc. is getting the unique, world rights from Orion Corp. to develop the oral prostate remedy, ODM-208, which the 2...
Cancer

Repurposing most cancers drug to stop organ harm in infectious illnesses

Editor -
Twelve years in the past, most cancers researchers at College of...
Prevention and Early Detection

New Insights Into Early Most cancers Biology

Editor -
Seventy p.c of cancer-related deaths are from most cancers sorts with no obtainable screening choices, underscoring the significance of detecting most cancers early...
1...1,5711,5721,573...1,671Page 1,572 of 1,671

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.